Search

everythinglearnresearchcommunity

for

Search:↓

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Higher hair calcium to magnesium ratios and lower chromium levels in hair may indicate insulin resistance in Korean men.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

AGA patients have higher heart disease risk.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.